bioXXmed Balance Sheet Health
Financial Health criteria checks 3/6
bioXXmed has a total shareholder equity of €469.9K and total debt of €7.3K, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are €683.8K and €213.9K respectively.
Key information
1.5%
Debt to equity ratio
€7.26k
Debt
| Interest coverage ratio | n/a |
| Cash | €612.83k |
| Equity | €469.94k |
| Total liabilities | €213.90k |
| Total assets | €683.85k |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: T5O0's short term assets (€666.1K) exceed its short term liabilities (€152.3K).
Long Term Liabilities: T5O0's short term assets (€666.1K) exceed its long term liabilities (€61.6K).
Debt to Equity History and Analysis
Debt Level: T5O0 has more cash than its total debt.
Reducing Debt: T5O0's debt to equity ratio has increased from 0% to 1.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if T5O0 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if T5O0 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.